Medical Marijuana Market

Global Market Study on Medical Marijuana: Europe to Register the Fastest Growth Through 2026

  • July-2018
  • PMRREP13897
  • 279 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Introduction

Medical marijuana is still in its introduction phase in the medical health industry. It is a potent product that is gaining mass acceptance globally, where Chinese medicines are already being manufactured by the use of these plants and that too with a long history associated.

Medical marijuana remains a big influence in the healthcare industry to treat cases that are not completely advisable with traditional medicines. Medical marijuana is just a normal marijuana plant that is processed to get the actual composition of cannabinoids, which is required to synthesize the product to be in use.

CBD is the main cannabinoid in use because of its zero-psychotic feeling as compared to others, but all the cannabionoids are generally calculated to form a specific medicine to treat disorders, which range from cancer, AIDS, multiple sclerosis, nerve damage, epilepsy, Parkinson’s disease, PTSD, anxiety, and arthritis, among others.

The marijuana plant is of two types’ sativa and indica. The manufactures use any of the two to manufacture medicines, having different types of properties when exposed to the body. Medical marijuana is mostly found in two forms, dried and extract, which are synthesized from the dry leaves making it a more potent and vast option with many products manufactured using marijuana extract such as oil concentrate, tinctures, edibles, spray, and topical, among others.

Find Out More about the Report Coverage

Companies

Company Profiles

  • Aphria Incorporation
  • The Peace Naturals Project
  • Aurora Cannabis Inc
  • Canopy Growth Corporation
  • CANNABIS SATIVA, INC.
  • Green Relief Inc.
  • GW PHARMACEUTICALS PLC
  • Insys Therapeutics, Inc.
  • Medical Marijuana, Inc.
  • MedReleaf Corporation
  • Others.

Market Value and Forecast

The global medical marijuana market is estimated to be worth US$ 12,209.9 Mn by 2018 end and is expected to expand at a CAGR of 15.9% over the forecast period of 2018 – 2026. North America accounted a large market share and was valued at US$ 3,538.7 Mn in 2017, and is expected to expand at a CAGR of 16.2% over the forecast period.    

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Market Dynamics

The growth of the global medical marijuana is primarily driven by increasing prevalence of conditions that require medical marijuana for the treatment, rising geriatric population in need of treatment for chronic diseases, awareness programs conducted by public and private associations, and growing number of medical marijuana clubs, which promote the quality associated with medical marijuana. However, manufacturers on a global level are engaged in developing products that should get recognition in order to be in use for a greater population. The legalization of medical marijuana in developing countries is expected to drive the demand for medical marijuana as an alternative for traditional medicines.

It makes the medical marijuana industry more accessible for the new players with fragmented company profiles, majority of them in situated in the U.S. and Canada. However, missing scientific cases for medical marijuana are confining the market to grow. Brand surge provides a positive share for the competitors to capture maximum market with already set distribution networks and regional space. Stringent FDA and other regulations are some of the factors expected to hamper the growth of the global medical marijuana market over the forecast period.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Key Regions

Geographically, North America is expected to be the dominant regional market by 2018 end and is expected to expand at a CAGR of 16.2% over the forecast period. Europe is expected to be a lucrative market in terms of revenue growth in the global medical marijuana market, registering a CAGR of 17.4% over the forecast period.

medical marijuana market

Explore Persistence Market Research’s expertise in promulgation of the business !

Key Players

Examples of some of the key players in the global medical marijuana market included in this report are GW Pharmaceuticals PLC, MedReleaf Corporation, Canopy Growth Corporation, Aphria Incorporation, Aurora Cannabis Inc, Medical Marijuana, Inc., Green Relief Inc., Cannabis Sativa, INC., Insys Therapeutics, Inc., and The Peace Naturals Project.

Market Segmentation

  • Product Type
  • Dried Form
  • Extract Form
  • Application
  • Pain management
  • Seizures
  • Others
  • Distribution Channel
  • Retail Pharmacy
  • E-Commerce
  • Reason
  • North America
  • Latin America
  • Europe
  • Asia-Pacific excluding China
  • China
  • Middle East & Africa

 

Media Release

Recommendations

Global Market Study on Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics: Increasing Production of Generic ADHD Drugs to Boost Market Growth

In Europe, Germany will lead the adhd therapeutics regional market due to the presence of strong distributors and sales channels. Besides, increasing the sales force is also likely to expand product reach across these two regions through distribution & collaboration agreements..

Global Market Study on Injectable Drug Delivery: Rising Demand for Connected Injectable Drug Delivery Devices being Witnessed

North America and Europe contributed maximum share to the global injectable drug delivery market, owing to the rising diagnosis and treatment of chronic diseases in these regions..

Global Opportunity Assessment of RNA-based Therapeutics and Vaccines: Genetic Diseases Indication Segment to Harness Maximum Revenue Share by 2026 End

The global RNA based Therapeutics and Vaccines market is expected to be account US$ 632.06 Mn in 2026, it is projected to increase at a CAGR of 70.4% through 2026. .

Global Market Study on Cushing's Syndrome and Acromegaly Treatment: Rising Demand for Non Invasive Treatment Trending the Global Market

In terms of revenue, the global Cushing’s syndrome and Acromegaly treatment market is projected to register a CAGR of 9.3% over the forecast period..

Talk Show:

The Rise of Intelligent Packaging

Personalized, Connected and Sustainable

November 18, 2021 11:00-11:45 AM PST (USA & Canada)
This is a LIVE session
Future Market Insights MarketNgage

Our Clients

Our Clients